Structure and function of lipopolysaccharides.
暂无分享,去创建一个
Elliott Bennett-Guerrero | Clett Erridge | Ian R Poxton | C. Erridge | E. Bennett-Guerrero | I. Poxton
[1] Adrian Ozinsky,et al. Toll-like receptors: key mediators of microbe detection. , 2002, Current opinion in immunology.
[2] K. Fukase,et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. , 2001, International immunology.
[3] P. Tobias,et al. MD-2 binds to bacterial lipopolysaccharide. , 2001, Journal of endotoxin research.
[4] Dirk E. Smith,et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.
[5] R. Medzhitov,et al. TIRAP: an adapter molecule in the Toll signaling pathway , 2001, Nature Immunology.
[6] M. Arditi,et al. Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling1 , 2001, The Journal of Immunology.
[7] R. Ulevitch,et al. Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex , 2001, The Journal of Biological Chemistry.
[8] A. Aderem,et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism , 2001, Nature Immunology.
[9] M. J. Cody,et al. Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages , 2001, Infection and Immunity.
[10] M. Nishijima,et al. Cutting Edge: Gln22 of Mouse MD-2 Is Essential for Species-Specific Lipopolysaccharide Mimetic Action of Taxol1 , 2001, The Journal of Immunology.
[11] T. McIntosh,et al. Preparation and Preclinical Evaluation of a Novel Liposomal Complete-Core Lipopolysaccharide Vaccine , 2000, Infection and Immunity.
[12] S. Vogel,et al. Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.
[13] J. Brisson,et al. Structure of the Bordetella pertussis 1414 endotoxin , 2000, FEBS letters.
[14] P. Ricciardi-Castagnoli,et al. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Monks,et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. , 2000, The Journal of clinical investigation.
[16] T. Kirikae,et al. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. , 2000, Biochemical and biophysical research communications.
[17] T. Yoshida,et al. Mouse Toll-like Receptor 4·MD-2 Complex Mediates Lipopolysaccharide-mimetic Signal Transduction by Taxol* , 2000, The Journal of Biological Chemistry.
[18] S. Opal,et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. , 1999, The Journal of infectious diseases.
[19] J. Govan,et al. Lipopolysaccharide chemotypes of Burkholderia cepacia. , 1999, Journal of medical microbiology.
[20] R. Thieringer,et al. Internalization of Monomeric Lipopolysaccharide Occurs after Transfer Out of Cell Surface Cd14 , 1999, The Journal of experimental medicine.
[21] D. Hood,et al. Haemophilus influenzae lipopolysaccharide. , 1999, Biochemical Society transactions.
[22] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[23] W. Goldman,et al. Signalling and cellular specificity of airway nitric oxide production in pertussis , 1999, Cellular microbiology.
[24] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[25] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[26] M. Sela,et al. Activation of Murine Macrophages by Lipoprotein and Lipooligosaccharide of Treponema denticola , 1999, Infection and Immunity.
[27] S. Wright. Toll, A New Piece in the Puzzle of Innate Immunity , 1999, The Journal of experimental medicine.
[28] L. Larivière,et al. Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.
[29] D. Hansen,et al. Klebsiella pneumoniae Lipopolysaccharide O Typing: Revision of Prototype Strains and O-Group Distribution among Clinical Isolates from Different Sources and Countries , 1999, Journal of Clinical Microbiology.
[30] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[31] R. Thieringer,et al. Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement. , 1998, Immunity.
[32] M. Blaser,et al. Simultaneous Expression of Type 1 and Type 2 Lewis Blood Group Antigens by Helicobacter pyloriLipopolysaccharides , 1998, The Journal of Biological Chemistry.
[33] A. Moran,et al. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. , 1997, The Journal of infectious diseases.
[34] B. Lindner,et al. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides , 1997, Journal of bacteriology.
[35] C. Janeway,et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.
[36] M. Wurfel,et al. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. , 1997, Journal of immunology.
[37] B. Appelmelk,et al. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. , 1996, FEMS immunology and medical microbiology.
[38] J. Goldberg,et al. Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. , 1996, Trends in microbiology.
[39] R. Rest,et al. Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate , 1996, Infection and immunity.
[40] J. Goldberg,et al. Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections , 1996, Science.
[41] A. Cox,et al. Structures of the two polymers present in the lipopolysaccharide of Burkholderia (Pseudomonas) cepacia serogroup O4. , 1995, European journal of biochemistry.
[42] I. Poxton,et al. Biological activity of Bacteroides lipopolysaccharide--reappraisal. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] G. Barclay,et al. Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species , 1995, Infection and immunity.
[44] G. Barclay,et al. A re-appraisal of the biological activity of bacteroides LPS. , 1995, Journal of medical microbiology.
[45] M. Jacques,et al. High-molecular-mass lipopolysaccharides are involved in Actinobacillus pleuropneumoniae adherence to porcine respiratory tract cells , 1994, Infection and immunity.
[46] V. Reinhold,et al. Detailed structural characterization of lipid A: electrospray ionization coupled with tandem mass spectrometry. , 1994, Analytical biochemistry.
[47] T. Kirikae,et al. Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] M. Wurfel,et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.
[49] M. Nowak,et al. Adaptive evolution of highly mutable loci in pathogenic bacteria , 1994, Current Biology.
[50] J. Mcghee,et al. Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines , 1993, Infection and immunity.
[51] P. Merino,et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? , 1993, Critical care medicine.
[52] G. Ramsay,et al. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides , 1993, Infection and immunity.
[53] M. Kastowsky,et al. Effect of pH on solubility and ionic state of lipopolysaccharide obtained from the deep rough mutant of Escherichia coli. , 1993, Biochemistry.
[54] M. Kastowsky,et al. Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide. , 1993, Immunobiology.
[55] T. Kirikae,et al. The chemical structure of bacterial endotoxin in relation to bioactivity. , 1993, Immunobiology.
[56] M. Apicella,et al. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. , 1993, Immunobiology.
[57] H. Flad,et al. Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures , 1992, Infection and immunity.
[58] J. Hildebrandt,et al. Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterization of immunostimulating contaminants in a batch of synthetic lipid X. , 1990, The Journal of biological chemistry.
[59] A. Weintraub,et al. Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. , 1989, Journal of immunology.
[60] B. Lindner,et al. Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. , 1988, European journal of biochemistry.
[61] A. Cross,et al. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. , 1987, The Journal of clinical investigation.
[62] H. Brade,et al. Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[63] E. Moxon,et al. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. , 1986, Microbial pathogenesis.
[64] K. Joiner,et al. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. , 1986, Journal of immunology.
[65] H. Mayer,et al. Lipopolysaccharides from Yersinia pestis. Studies on lipid A of lipopolysaccharides I and II. , 1985, European journal of biochemistry.
[66] D L Diedrich,et al. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. , 1985, Canadian journal of microbiology.
[67] E. Rietschel,et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. , 1985, European journal of biochemistry.
[68] R. Tharanathan,et al. The structure of the polysaccharide moiety of Rhodopseudomonas sphaeroides ATCC 17023 lipopolysaccharide. , 1984, European journal of biochemistry.
[69] M. Frank,et al. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide , 1984 .
[70] T. Pitt,et al. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa , 1984, Infection and immunity.
[71] K. Tanamoto,et al. Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate , 1984, Infection and immunity.
[72] R. Hancock,et al. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains , 1983, Infection and immunity.
[73] R. Hancock,et al. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains , 1983, Journal of bacteriology.
[74] S. Wilkinson,et al. Studies of lipopolysaccharides from Pseudomonas aeruginosa. , 1975, European journal of biochemistry.
[75] J. Spitzer,et al. Cellular and molecular aspects of endotoxin reactions : proceedings of the 1st Congress of the International Endotoxin Society, San Diego, 9-12 May 1990 , 1990 .
[76] A. Weintraub,et al. Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. , 1990, Reviews of infectious diseases.
[77] E. Rietschel,et al. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. , 1987, Progress in clinical and biological research.
[78] L. Larsson,et al. A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis , 1987, Nature.